Importance of "acknowledging and reducing treatment uncertainty" in appraisal and revalidation 4 and its call on doctors to consider whether they could do more to support medical research.
3 In particular, we are pleased to see that the GMC is now urging doctors to raise patients' awareness of the importance of research; to look for opportunities for themselves and patients to become involved in research studies, and to tell patients about them so they can decide if they would like to take part; and, lastly, to support patients who choose to take part in studies.
We share the council's view that such actions will reduce risks for patients. Indeed, we believe that acknowledging uncertainties about the effects of treatments and seeking to reduce them by increasing the number of patients enrolled in well designed clinical trials is a more patient centred form of "reflective practice" than the reflection currently being endorsed by the GMC. We urge the GMC to take the next (small) step and give "acknowledging and reducing treatment uncertainty" the same degree of emphasis in appraisal and revalidation as is currently devoted to reflective practice.
